Chondro-osteoma

Osteochondromas are a relatively common imaging finding, accounting for 10-15% of all bone tumors and approximately 35% of all benign bone tumors. Although usually thought of as a benign bone tumor, they may be thought of as a developmental anomaly. They are frequently asymptomatic and have very low malignant potential if sporadic and solitary.

Epidemiology

Osteochondromas develop during childhood (period of most rapid skeletal growth), but once formed remain for the rest of the individual's life. They can present at any age and are most frequently found incidentally.

They are usually sporadic, but can be part of:

• hereditary multiple exostoses (HME): also known as diaphyseal aclasis
• Trevor disease: also known as dysplasia epiphysealis hemimelica

Malignant transformation occurs in the cartilage cap, and is uncommon in sporadic solitary osteochondromas (~1%), whereas in the setting of hereditary multiple exostoses the rate is much higher (5-25%)

Pathology

Osteochondromas are considered a chondroid neoplasm and are primarily a part of the growth plate which separates and continues growing independently, without an associated epiphysis, usually away from the nearby joint. The medullary cavity is continuous with the parent bone, and hyaline cartilage caps them. Osteochondromas can be congenital or occur as a result of previous trauma to the growth plate, including previous irradiation.

Feel free to share your research work on related topics in Journal of Orthopedic Oncology which offers information in all aspects of primary, malignant tumors. Osteosarcoma, Ewing's sarcoma, chondrosarcoma, chordoma, and soft tissue sarcomas etc., it also deals with diagnostic methods, therapeutic approaches, clinical, laboratory research and reconstructive techniques.

Journal uses Editorial Tracking System for quality in review process. Editorial Manager is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Orthopedics & Oncology or outside experts; at least two independent reviewer’s approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system.

Journal Considers Research article, Review articles, editorial, letter, case reports, short communications, original articles from leading scientists and scholars around the world in all areas of related to Malignantosteoid, Multilobular tumour of bone, Chondrosarcoma, Chordoma, Osteosarcoma, Ewing's sarcomaetc., which come under the scope of the journal.

You may submit your manuscript as an e-mail attachment to the Editorial Office at  orthooncol@scholarlymed.com; joo@jpeerreview.org

Regards,

Stella

Editorial Team

Journal of Orthopedic Oncology